Physician

Mark Jeffery Mcnabb, D.O.

According to 2025 Medicare claims, Mark Mcnabb, D.O. (NPI: 1942337522) practices internal medicine in the Cape Girardeau, MO-IL market, with the plurality of this provider's patient population coming from Cape Girardeau, MO. This provider's primary affiliated billing organization is SOUTHERN MISSOURI INTERNAL MEDICINE, PC (NPI: 1750625844) and primary practice location at 63701-2609. Mcnabb is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), The Rural Advantage LLC (ACO ID: A5257), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Mcnabb's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 439 traditional Medicare patients, billed 6,844 HCPCS/CPT codes, and received $231,152 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 14,119 prescription claims across 471 beneficiaries totaling $1,164,154 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,555 claims. Open Payments data shows 37 records totaling $653. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, reported payments moved sharply higher in recent years, from $45,786 to $139,113.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	461	7,445	$192,580
2016	458	6,775	$226,602
2017	467	7,342	$233,247
2018	478	7,511	$255,027
2019	479	7,640	$251,941
2020	488	7,205	$234,000
2021	463	6,999	$245,193
2022	433	6,752	$241,793
2023	438	6,830	$236,142
2024	439	6,844	$231,152

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	408	14,873	$912,743
2016	409	14,517	$935,373
2017	413	14,876	$1,006,643
2018	436	15,213	$1,061,539
2019	456	15,117	$1,019,347
2020	452	14,755	$1,095,332
2021	443	13,168	$968,517
2022	442	13,685	$1,031,810
2023	447	14,192	$1,332,154
2024	471	14,119	$1,164,154

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	322	991	$52,720
2016	306	931	$43,043
2017	540	1,196	$33,524
2018	549	1,445	$45,959
2019	671	1,565	$55,233
2020	666	1,818	$103,947
2021	585	1,551	$109,081
2022	704	1,843	$146,424
2023	696	1,837	$159,256
2024	633	1,555	$132,181

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	396	595	$103
99497	Advance care planning, first 30 minutes	370	370	$65
80061	Blood test, lipids (cholesterol and triglycerides)	386	613	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	389	412	$8
81002	Urinalysis, manual test	402	739	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	172	6,208	$196,958
Eliquis	Apixaban	223	8,173	$162,130
Jardiance	Empagliflozin	157	5,709	$103,304
Xarelto	Rivaroxaban	85	4,311	$79,181
Mounjaro	Tirzepatide	48	1,350	$47,299

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	27	154	$59,398
E0601	Continuous positive airway pressure (cpap) device	Y	41	224	$7,556
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	69	128	$7,141
A7031	Face mask interface, replacement for full face mask, each	N	28	69	$6,789
A7030	Full face mask used with positive airway pressure device, each	N	29	64	$6,676

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$653	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Jeffery Mcnabb, D.O.?

Tedicare shows public-source Medicare data for Mark Jeffery Mcnabb, D.O. (NPI 1942337522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Jeffery Mcnabb, D.O. have ACO affiliation data?

Mark Jeffery Mcnabb, D.O. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616), The Rural Advantage LLC (MSSP, ACO ID A5257), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Mark Jeffery Mcnabb, D.O.?

Mark Jeffery Mcnabb, D.O. is linked to SOUTHERN MISSOURI INTERNAL MEDICINE, PC (billing NPI 1750625844) in the available physician profile data.

Does Mark Jeffery Mcnabb, D.O. have Open Payments data?

Mark Jeffery Mcnabb, D.O. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.